Novartis AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7,616	11,435	11,459	13,393	7,517	12,407
Short-Term Investments	74	155	1,998	1,035	11,413	15,922
Cash & Short-Term Investments	7,690	11,590	13,457	14,428	18,930	28,329
Cash Growth	9.86%	-13.87%	-6.73%	-23.78%	-33.18%	145.00%
Accounts Receivable	9,636	8,937	7,423	7,107	8,066	8,005
Other Receivables	218	205	133	426	268	278
Total Trade Receivables	9,854	9,142	7,556	7,533	8,334	8,283
Inventory	6,220	6,269	5,723	5,913	7,175	6,666
Other Current Assets	3,587	3,459	2,968	2,607	2,471	2,440
Total Current Assets	27,351	30,460	29,704	30,481	36,910	45,718
Net Property, Plant & Equipment	12,267	12,352	10,873	10,924	12,195	13,106
Other Intangible Assets	42,074	29,411	26,915	26,879	31,644	34,182
Goodwill	26,767	25,567	24,756	23,341	29,301	29,595
Long-Term Investments	2,371	2,446	2,134	2,812	2,554	3,241
Other Long-Term Assets	11,203	10,713	7,864	5,508	4,849	5,953
Total Assets	122,033	110,949	102,246	99,945	117,453	131,795
Accounts Payable	4,258	4,456	4,572	4,926	5,146	5,553
Accrued Expenses	15,316	14,988	14,054	13,166	14,795	15,670
Current Portion of Long-Term Debt	9,588	5,602	8,232	6,175	5,931	6,295
Current Portion of Leases	274	263	235	230	251	275
Other Current Liabilities	2,312	1,969	1,599	1,893	2,533	2,415
Total Current Liabilities	31,748	27,278	28,692	26,390	28,656	30,208
Long-Term Debt	37,489	27,935	21,366	18,436	20,244	22,902
Long-Term Leases	1,663	1,657	1,568	1,598	1,538	1,621
Other Long-Term Liabilities	9,187	7,530	6,494	6,771	7,592	9,242
Total Long-Term Liabilities	48,339	37,122	29,428	26,805	29,374	33,765
Total Liabilities	80,087	64,400	58,120	53,195	58,030	63,973
Common Stock	736	766	793	825	890	901
Treasury Stock	-49	-50	-53	-41	-92	-48
Retained Earnings	40,855	45,414	43,306	45,883	58,544	66,802
Total Common Shareholders' Equity	41,542	46,130	44,046	46,667	59,342	67,655
Minority Interest	404	419	80	83	81	167
Shareholders' Equity	41,946	46,549	44,126	46,750	59,423	67,822
Total Liabilities & Equity	122,033	110,949	102,246	99,945	117,453	131,795
Total Debt	49,014	35,457	31,401	26,439	27,964	31,093
Net Cash (Debt)	-41,324	-23,867	-17,944	-12,011	-9,034	-2,764
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-21.47	-12.21	-8.82	-5.74	-4.11	-1.22
Book Value	41,542	46,130	44,046	46,667	59,342	67,655
Book Value Per Share	21.58	23.60	21.64	22.31	27.01	29.94
Tangible Book Value	-27,299	-8,848	-7,625	-3,553	-1,603	3,878
Tangible Book Value Per Share	-14.18	-4.53	-3.75	-1.70	-0.73	1.72

SEC Filings: 10-K · 10-Q